News
📈 Stocks
Moderna and Merck Shares Surge After Melanoma Vaccine Trial Success
(56 days ago)
Moderna (MRNA) and Merck (MRK) shares surged after a large trial demonstrated their investigational mRNA melanoma vaccine reduced recurrence, lifting the oncology…